摘要
目的探讨血流感染分离的大肠埃希菌耐药性,感染的临床特点、治疗方案及其预后。方法收集2017年1-12月诊断为大肠埃希菌血流感染的住院患者临床资料进行回顾性分析,采用SPSS21.0统计学软件进行数据分析处理。结果131例患者白细胞数(WBC)平均为(12.0±7.9)×10^9/L,检测94例患者C反应蛋白(CRP)平均为(108.9±76.9)mg/L。131例患者住院时间平均22.2d,41例(31.3%)合并其他细菌感染。细菌耐药率>50%的抗菌药物有头孢呋辛、头孢唑林、头孢噻肟、头孢曲松、氨苄西林;耐药率<5%的抗菌药物有亚胺培南、厄他培南、哌拉西林-他唑巴坦、头孢哌酮-舒巴坦、头孢西丁、阿米卡星。大肠埃希菌血流感染多见于脑血管疾病(34.4%)、肿瘤疾病(26.7%)等患者,常见于重症医学科、泌尿外科等科室。将131例大肠埃希菌血流感染患者分为中青年组(<60岁)和老年组(≥60岁),老年组合并其他部位感染、细菌多重耐药率、脑血管疾病、慢性肾病、糖尿病均高于中青年组,差异有统计学意义(P<0.05)。结论大肠埃希菌血流感染容易合并其他部位及其他菌种的感染。老年患者由于基础疾病多、免疫功能相对低下等原因,更易发生重症感染及复合感染。
Objective To investigate the antimicrobial resistance,clinical features,treatment and prognosis of bloodstream infections caused by Escherichia coli.Methods The clinical data of the inpatients with diagnosis of Escherichia coli bloodstream infection during the period from January to December 2017 were analyzed retrospectively.SPSS 21.0 statistical software was used for data processing and analysis.Results A total of 131 patients were included in this analysis.The mean white blood cell count (WBC) was (12.0±7.9)×10^9/L and C reactive protein (CRP) was (108.9±76.9) mg/L.The average length of hospital stay was 22.2 days.Complex bacterial infection was identified in 41 (31.3%) patients.More than 50% of the E.coli isolates were resistant to cefuroxime,cefazolin,cefotaxime,ceftriaxone,and ampicillin.Less than 5% of the E.coli isolates were resistant to imipenem, ertapenem,piperacillin-tazobactam,cefoperazone-sulbactam,cefoxitin,and amikacin.E.coli bloodstream infections were more common in the patients with cerebrovascular disease (34.4%),oncological disease (26.7%),or other underlying disease,and more prevalent in ICU and Department of Urology.The 131 cases of E.coli bloodstream infection were analyzed in terms of patient age (<60 or ≥60 years old).The elderly patients were associated with significantly higher proportion of concomitant infection sites, multidrug resistance,underlying cerebrovascular disease,chronic kidney disease or diabetes mellitus compared to younger patients (P<0.05).Conclusions Bloodstream infections caused by E.coli are usually associated with infections in other sites and other pathogens.The elderly patients are more likely to develop severe or complex infections due to more underlying diseases and impaired immune function.
作者
展冠军
陆瑾
孙进华
刘静
ZHAN Guanjun;LU Jin;SUN Jinhua;LIU Jing(Department of pharmacy,Zhongda Hospital Affiliated to Southeast University,Nanjing 210009,China)
出处
《中国感染与化疗杂志》
CAS
CSCD
北大核心
2019年第4期381-385,共5页
Chinese Journal of Infection and Chemotherapy
基金
江苏省药学会奥赛康医院药学基金项目(A201744)
关键词
大肠埃希菌
血流感染
耐药性
临床分析
Escherichia coli
bloodstream infection
antimicrobial resistance
clinical analysis